TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/11/2026
Back to search
Official data from USPTO
ATLAS ANTIBODIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
03/13/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
01/22/2013
Registration date
06/24/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/29/2024
Last transaction
03/13/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/13/2013
First use in commerce
03/14/2013
Drawing code
3
Owner type
03
Owner location
Stockholm, SE
Examiner
BEVERLY, JOSETTE MICHELLE
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "ATLAS ANTIBODIES" with a figurative design element of a man to the left of the words.
Holders and representatives
Holders
Atlas Antibodies AB
Representatives
Mari-Elise Paul McBrayer PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical substances based on affinity reagents of immunoglobulin or non-immunoglobulin origin for cancer diagnosticsprognosticstreatment; pharmaceutical preparations for molecular or cellular targetingprotein detectionin-vivo imagingmainly for cancer cellsin-vitro or in-vivoall for medical or diagnostic purposes; biological preparations for pharmaceutical use for cancer diagnosticsprognosticstreatment
Class 42
Scientific and medical research and developments within the field of biochemistry and biotechnologydiagnostics and pharmaceutical or medical substances and preparations
Publications
History of USPTO decisions and trademark events.
56 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/11/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/11/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/11/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/11/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/29/2024
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/29/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/29/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/29/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
06/17/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/10/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/10/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/15/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/15/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/15/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/24/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/09/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/09/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
07/08/2020
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
06/01/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/30/2020
E815
TEAS SECTION 8 & 15 RECEIVED
04/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/29/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/29/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/24/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/10/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/10/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
06/24/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/22/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/21/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/19/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/28/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/25/2014
IUAF
USE AMENDMENT FILED
04/07/2014
EISU
TEAS STATEMENT OF USE RECEIVED
04/07/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/04/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2014
PUBO
PUBLISHED FOR OPPOSITION
01/07/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/18/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/03/2013
ALIE
ASSIGNED TO LIE
11/29/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/11/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/11/2013
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/11/2013
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/14/2013
GNSL
LETTER OF SUSPENSION E-MAILED
05/14/2013
CNSL
SUSPENSION LETTER WRITTEN
05/14/2013
DOCK
ASSIGNED TO EXAMINER
05/05/2013
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
01/26/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/25/2013
NWAP
NEW APPLICATION ENTERED
01/25/2013
Continuous trademark protection
Get notified about every new filing that threatens ATLAS ANTIBODIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.